- $150.41m
- $138.24m
- $26.77m
- 39
- 10
- 45
- 22
Annual income statement for Stereotaxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28.9 | 26.6 | 35 | 28.1 | 26.8 |
Cost of Revenue | |||||
Gross Profit | 22.8 | 19 | 23.2 | 18.5 | 14.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 33.7 | 33.3 | 45.7 | 46.9 | 48.6 |
Operating Profit | -4.83 | -6.71 | -10.7 | -18.8 | -21.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.59 | -6.65 | -10.7 | -18.3 | -20.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.59 | -6.65 | -10.7 | -18.3 | -20.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.59 | -6.65 | -10.7 | -18.3 | -20.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.02 | -8.02 | -12.1 | -19.6 | -22.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.095 | -0.11 | -0.189 | -0.258 | -0.273 |